Financhill
Back

Titan Pharmaceuticals Quote, Financials, Valuation and Earnings

Election Shock on August 19th?

Click here now to see the evidence I've gathered.
Sell
40

TTNP
Titan Pharmaceuticals

Last Price:
6.97
Seasonality Move:
90.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!

Titan Pharmaceuticals Price Quote

$6.97

Titan Pharmaceuticals Key Stats

Sell
40
Titan Pharmaceuticals (TTNP) is a Sell

Day range:
$6.85 - $7.05
52-week range:
$5.00 - $16.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.96%

Volume:
2.6K
Avg. volume:
11.6K
1-year change:
-53.97%
Market cap:
$6.4M
Revenue:
$1K
EPS:
$-7.41

How Much Does Titan Pharmaceuticals Make?

Data Unavailable

Is Titan Pharmaceuticals Growing As A Company?

Data Unavailable

Titan Pharmaceuticals Stock Price Performance

What Is Titan Pharmaceuticals 52-Week High & Low?

Titan Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Titan Pharmaceuticals?

Is Titan Pharmaceuticals Cash Flow Positive?

  • What Is TTNP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$7.1M
  • What Is Titan Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10M
  • What Is Titan Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Titan Pharmaceuticals Return On Invested Capital

Data Unavailable

Titan Pharmaceuticals Earnings Date & Stock Price

Titan Pharmaceuticals Competitors

  • Who Are Titan Pharmaceuticals's Competitors?
    Below is a list of companies who compete with Titan Pharmaceuticals or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Allurion Technologies Inc (ALUR)
    • Armata Pharmaceuticals Inc (ARMP)
    • Outset Medical Inc (OM)
    • Protalix BioTherapeutics Inc (PLX)

Titan Pharmaceuticals Dividend Yield

Data Unavailable

Titan Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 14.29%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 140.00
Upside from Last Price: 1908.61%

Major Shareholders

  • How many TTNP shares are owned by institutional investors?
    1.1M TTNP shares are owned by institutional investors
  • How many TTNP shares are owned by insiders?
    0 TTNP shares are owned by insiders